1
|
Batalha ADDSJ, Souza DCDM, Ubiera RD, Chaves FCM, Monteiro WM, da Silva FMA, Koolen HHF, Boechat AL, Sartim MA. Therapeutic Potential of Leaves from Fridericia chica (Bonpl.) L. G. Lohmann: Botanical Aspects, Phytochemical and Biological, Anti-Inflammatory, Antioxidant and Healing Action. Biomolecules 2022; 12:biom12091208. [PMID: 36139047 PMCID: PMC9496332 DOI: 10.3390/biom12091208] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 08/21/2022] [Accepted: 08/26/2022] [Indexed: 11/16/2022] Open
Abstract
Plants of the species Fridericia chica (Bonpl.) L. G. Lohmann (Bignoniaceae), which are widely distributed in Brazil and named crajiru in the state of Amazonas, are known in folk medicine as a traditional medicine in the form of a tea for the treatment of intestinal colic, diarrhea, and anemia, among other diseases. The chemical analysis of extracts of the leaves has identified phenolic compounds, a class of secondary metabolites that provide defense for plants and benefits to the health of humans. Several studies have shown the therapeutic efficacy of F. chica extracts, with antitumor, antiviral, wound healing, anti-inflammatory, and antioxidant activities being among the therapeutic applications already proven. The healing action of F. chica leaf extract has been demonstrated in several experimental models, and shows the ability to favor the proliferation of fibroblasts, which is essential for tissue repair. The anti-inflammatory activity of F. chica has been clearly demonstrated by several authors, who suggest that it is related to the presence of 3-deoxyanthocyanidins, which is capable of inhibiting pro-inflammatory pathways such as the kappa B (NF-kB) nuclear transcription factor pathway. Another important effect attributed to this species is the antioxidant effect, attributed to phenolic compounds interrupting chain reactions caused by free radicals and donating hydrogen atoms or electrons. In conclusion, the species Fridericia chica has great therapeutic potential, which is detailed in this paper with the objective of encouraging new research and promoting the sum of efforts for the inclusion of herbal medicines in health systems around the world.
Collapse
Affiliation(s)
| | - Damy Caroline de Melo Souza
- Basic and Applied Graduate Program—PPGIBA, Biological Science Institute, Federal University of Amazonas, Manaus 69080-900, Brazil
| | - Rosmery Duran Ubiera
- Basic and Applied Graduate Program—PPGIBA, Biological Science Institute, Federal University of Amazonas, Manaus 69080-900, Brazil
| | | | - Wuelton Marcelo Monteiro
- Tropical Medicine Graduate Program, Amazonas State University—UEA, Manaus 69040-000, Brazil
- Tropical Medicine Foundation Heitor Vieira Dourado (FMT-HVD), Manaus 69040-000, Brazil
| | | | - Hector Henrique Ferreira Koolen
- Tropical Medicine Graduate Program, Amazonas State University—UEA, Manaus 69040-000, Brazil
- Research Group in Metabolomics and Mass Spectrometry, Amazonas State University, Manaus 690065-130, Brazil
| | - Antônio Luiz Boechat
- Basic and Applied Graduate Program—PPGIBA, Biological Science Institute, Federal University of Amazonas, Manaus 69080-900, Brazil
- Laboratory of Innovative Therapies, Department of Parasitology, Amazonas State University—UEA, Manaus 69080-900, Brazil
| | - Marco Aurélio Sartim
- Basic and Applied Graduate Program—PPGIBA, Biological Science Institute, Federal University of Amazonas, Manaus 69080-900, Brazil
- Tropical Medicine Graduate Program, Amazonas State University—UEA, Manaus 69040-000, Brazil
- Research & Development Department, Nilton Lins Foundation, Manaus 69058-030, Brazil
- Correspondence:
| |
Collapse
|
2
|
Determination of Senegenin and Tenuifolin in Mouse Blood by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry and Their Pharmacokinetics. Int J Anal Chem 2022; 2022:3401355. [PMID: 35432545 PMCID: PMC9010192 DOI: 10.1155/2022/3401355] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2022] [Revised: 03/28/2022] [Accepted: 03/30/2022] [Indexed: 12/13/2022] Open
Abstract
An ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the determination of senegenin and tenuifolin in mouse blood was developed. The pharmacokinetics of senegenin and tenuifolin in mice after intravenous (5 mg/kg) and oral (60 mg/kg) administration were studied, and the absolute bioavailability was calculated. A CORTECS T3 column was used, with a column temperature set at 40°C. The mobile phase was acetonitrile and 0.1% formic acid. Gradient elution was adopted, using a flow rate of 0.4 mL/min and an elution time of 4 min. Quantitative analysis was performed using electrospray ionization (ESI) with multiple reaction monitoring (MRM) in negative ion mode. Institute of Cancer Research (ICR) mice were bled from the tail vein after intravenous or oral administration of senegenin and tenuifolin. A UPLC-MS/MS method was established to determine the blood concentrations of each drug in mice, and the noncompartmental model was used to fit the pharmacokinetic parameters. Senegenin and tenuifolin showed a good linear relationship (r > 0.995) within a concentration range of 5–400 ng/mL in mouse blood. The intraday precision was <12%, the interday precision was <14%, and the accuracy was 87–109%. The recovery was >88%, and the matrix effect was 87–94%. The oral bioavailability of senegenin and tenuifolin in mice was 8.7% and 4.0%, respectively. The established UPLC-MS/MS method is suitable for pharmacokinetic studies of senegenin and tenuifolin in mice.
Collapse
|